Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gabriela Hobbs, M.D.

Concepts (290)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myeloproliferative Disorders2120246136.150 Why?
Polycythemia Vera1120241614.760 Why?
Thrombocythemia, Essential720221133.780 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive920236863.480 Why?
Primary Myelofibrosis1020242093.380 Why?
Blast Crisis320211022.040 Why?
Leukemia, Myeloid, Chronic-Phase32021371.090 Why?
Protein Kinase Inhibitors10202356711.000 Why?
Leukemia, Myeloid, Acute16202336130.870 Why?
Pregnancy Complications, Hematologic220211790.790 Why?
Hypertension, Pulmonary2202315780.790 Why?
STAT Transcription Factors320191880.730 Why?
Hypereosinophilic Syndrome12021970.720 Why?
Janus Kinase 2620245600.700 Why?
Leukemia3202215220.680 Why?
Thrombosis2202329420.600 Why?
Janus Kinases220192480.580 Why?
Neoplasms92023221700.570 Why?
Antigens, CD19120204240.570 Why?
Splenomegaly120171890.560 Why?
Live Birth120205110.550 Why?
Metformin120249060.540 Why?
Abortion, Spontaneous120205330.500 Why?
Antineoplastic Combined Chemotherapy Protocols112022117420.500 Why?
Oncogene Proteins, Fusion5202216060.500 Why?
Disease Management7202425080.500 Why?
HSP90 Heat-Shock Proteins120174240.480 Why?
Atrial Fibrillation2202351270.460 Why?
Sleep Initiation and Maintenance Disorders1202310810.440 Why?
Hematopoietic Stem Cell Transplantation6202356710.430 Why?
Venous Thromboembolism2202318660.430 Why?
Fatigue1202015520.430 Why?
Antineoplastic Agents72022136390.410 Why?
Venous Thrombosis1202113030.390 Why?
Stroke2202397570.360 Why?
Immunotherapy, Adoptive1202014690.350 Why?
Humans8020247615040.340 Why?
Molecular Targeted Therapy3201828110.340 Why?
Pyrimidines8202430280.330 Why?
Cardiovascular Diseases32024155000.320 Why?
Medical Oncology6202223210.320 Why?
Heart Failure22022116690.300 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma3202215510.300 Why?
Pyrazoles7202420090.300 Why?
Nitriles520249710.290 Why?
Patient Preference120159240.290 Why?
Philadelphia Chromosome420201170.280 Why?
Hemorrhage3202334240.270 Why?
Hematologic Neoplasms4202218960.270 Why?
Azepines220193290.270 Why?
Disease Susceptibility2202417870.250 Why?
Eosinophilia220205600.250 Why?
Pyrrolidines220243380.240 Why?
Thrombocytopenia2202211810.240 Why?
Mutation122021300520.230 Why?
Models, Biological1202094690.230 Why?
Genetic Predisposition to Disease32021179040.230 Why?
Family1201531940.230 Why?
Phlebotomy220211370.210 Why?
Prognosis122020296250.210 Why?
Cytarabine620196970.200 Why?
Patient Satisfaction1201534610.200 Why?
Decision Making2201839290.200 Why?
Calreticulin220191140.190 Why?
Platelet Count220227810.190 Why?
Clinical Trials, Phase II as Topic320226290.190 Why?
Signal Transduction42019234450.180 Why?
Hematology120232430.170 Why?
Risk Factors82023742060.170 Why?
Niacinamide120214130.170 Why?
Chemokine CXCL10120203160.160 Why?
Female3020233926440.160 Why?
Receptor, Platelet-Derived Growth Factor beta120201840.160 Why?
RNA Helicases120201440.160 Why?
Middle Aged2320222208950.160 Why?
Interferons120227060.160 Why?
Thrombocytosis12018890.150 Why?
Aged2320231692890.150 Why?
Male2820223608040.140 Why?
Phenylurea Compounds120205290.140 Why?
Mastocytosis, Systemic120181030.140 Why?
Pyridines2202028750.140 Why?
Retrospective Studies112022806360.140 Why?
Glutarates120182430.140 Why?
Anticoagulants2202348120.140 Why?
Peripheral Blood Stem Cell Transplantation120182630.140 Why?
Risk Assessment72023239950.140 Why?
Spleen1202322950.140 Why?
Treatment Outcome102022646800.130 Why?
Leukemia, Myeloid120196940.130 Why?
Transplantation Conditioning1202315900.130 Why?
Transplantation, Homologous3202048060.130 Why?
Anxiety4202345730.130 Why?
Adult1920212211770.130 Why?
Antifungal Agents120207520.120 Why?
Colorectal Neoplasms1201569350.120 Why?
Research1202319820.120 Why?
Hospice Care120216780.120 Why?
Young Adult102021592430.120 Why?
Anilides120174110.120 Why?
DNA Helicases120208510.120 Why?
Pregnancy Complications, Neoplastic120162580.120 Why?
fms-Like Tyrosine Kinase 3120174950.110 Why?
Bradyrhizobium12013160.110 Why?
Abnormalities, Drug-Induced120163390.110 Why?
Drug Discovery1202110510.110 Why?
Interferon-beta120153450.110 Why?
Clinical Trials as Topic3201880020.110 Why?
Quality of Life72023133670.110 Why?
Anemia1202215090.110 Why?
Stress Disorders, Post-Traumatic2202145750.110 Why?
Infection Control120209810.100 Why?
Remission Induction4202223960.100 Why?
Respiratory Insufficiency1202112300.100 Why?
Isocitrate Dehydrogenase120189380.100 Why?
Immunoconjugates120199540.100 Why?
Drug Evaluation, Preclinical1201713340.100 Why?
Fertility120167710.100 Why?
Aspirin2202131330.100 Why?
Aged, 80 and over92021589760.100 Why?
Maximum Tolerated Dose320198830.100 Why?
Hypoglycemic Agents1202430850.100 Why?
Chromosome Aberrations1201817680.100 Why?
Incidence52022213530.100 Why?
Anaphylaxis120187570.090 Why?
Disease-Free Survival2201968140.090 Why?
Boston2202193260.090 Why?
Affect1201914860.090 Why?
Disease Progression42021135060.090 Why?
Patient Care Team2202025210.090 Why?
Cause of Death1202136830.090 Why?
Antibodies, Viral1202231560.090 Why?
Opportunistic Infections120133760.090 Why?
Lung Neoplasms12015133800.090 Why?
Pregnancy32021298740.090 Why?
Point Mutation1201515950.090 Why?
Needs Assessment1201611390.090 Why?
Hospitals1202338820.090 Why?
Hospitalization32021107230.090 Why?
Mortality1202129010.090 Why?
Phosphoproteins1201824480.080 Why?
Polyethylene Glycols1201511890.080 Why?
Terminal Care1202117600.080 Why?
Stem Cell Transplantation1201816000.080 Why?
Vaccination1202233840.080 Why?
Graft vs Host Disease2202030290.080 Why?
Platelet Aggregation Inhibitors1202127510.080 Why?
Patient Readmission1202332700.080 Why?
Immunologic Factors1201815890.080 Why?
Myelodysplastic Syndromes1201913940.080 Why?
Communicable Diseases120178750.080 Why?
Mitoxantrone220191480.080 Why?
Idarubicin22019590.080 Why?
Patient Admission1201613670.080 Why?
Carcinoma, Hepatocellular1202022980.070 Why?
Acute Kidney Injury1202019240.070 Why?
Neoplasm Proteins1201936170.070 Why?
Clinical Competence1202347920.070 Why?
Randomized Controlled Trials as Topic22022102090.070 Why?
Neoplasms, Second Primary1201510520.070 Why?
Fusion Proteins, bcr-abl220204310.070 Why?
Etoposide220196340.070 Why?
Survival Rate22018127250.070 Why?
Receptors, Thrombopoietin220191600.070 Why?
CD8-Positive T-Lymphocytes1202045800.070 Why?
Genotype12021129900.070 Why?
Enzyme Inhibitors1201737120.070 Why?
Fetal Blood1201313470.070 Why?
Age Factors22020183950.070 Why?
Genetic Variation1202165670.070 Why?
Intensive Care Units1201937450.060 Why?
Insurance Coverage1201719400.060 Why?
Phenotype12023165910.060 Why?
Practice Guidelines as Topic2202073900.060 Why?
Colon1201317920.060 Why?
Hospital Mortality1201952940.060 Why?
In Situ Hybridization, Fluorescence2202225100.060 Why?
Colitis1201312330.060 Why?
Insurance, Health1201724980.060 Why?
Liver Neoplasms1202043200.060 Why?
T-Lymphocytes12022101940.060 Why?
Phosphatidylinositol 3-Kinases2202428650.060 Why?
Follow-Up Studies42019391060.050 Why?
Coronavirus Infections1202030840.050 Why?
Pneumonia, Viral1202032040.050 Why?
Cohort Studies22021414870.050 Why?
SEER Program2201714500.050 Why?
Nuclear Pore Complex Proteins120221630.050 Why?
Isoxazoles120222320.050 Why?
Animals420211684590.040 Why?
Prospective Studies42021544250.040 Why?
Benzazepines120223100.040 Why?
Surge Capacity12020480.040 Why?
Boron Compounds120221820.040 Why?
Acute Disease2202272370.040 Why?
Accreditation120234730.040 Why?
North America1202312760.040 Why?
Vincristine1202210360.040 Why?
Drug Resistance, Neoplasm3201953050.040 Why?
Genes, sry1201840.040 Why?
Glycine120226630.040 Why?
Clinical Trials, Phase III as Topic120228570.040 Why?
Histamine Antagonists12018920.040 Why?
mRNA Cleavage and Polyadenylation Factors120181050.040 Why?
Recurrence2202284650.040 Why?
Bone Marrow2201829110.040 Why?
Cytogenetic Analysis120182700.040 Why?
Resource Allocation120203500.040 Why?
Workflow120228510.040 Why?
Expert Testimony120203640.040 Why?
Histocompatibility120183170.040 Why?
Death120216760.040 Why?
Drug Evaluation120186410.040 Why?
Anthracyclines120192840.030 Why?
Receptor, Platelet-Derived Growth Factor alpha120183680.030 Why?
Societies, Medical2201839050.030 Why?
World Health Organization1202213220.030 Why?
United States62021723340.030 Why?
Combined Modality Therapy2201885290.030 Why?
Transplantation Chimera120185940.030 Why?
Marital Status120174260.030 Why?
Fibrosis1202220490.030 Why?
Proto-Oncogene Proteins c-kit120187270.030 Why?
Translocation, Genetic1202013930.030 Why?
Survival Analysis22017100900.030 Why?
Biopsy2201867660.030 Why?
Hydroxyurea120152840.030 Why?
Delivery of Health Care2202253360.030 Why?
Bone Marrow Cells1202124160.030 Why?
Proto-Oncogene Proteins c-akt1202224550.030 Why?
Immunophenotyping1201818700.030 Why?
Physician's Role120209170.030 Why?
Fatal Outcome1201818340.030 Why?
Administration, Oral1202140210.030 Why?
Palliative Care2202135980.030 Why?
United States Food and Drug Administration1202116640.030 Why?
Consensus1202231230.030 Why?
Paraffin Embedding120133020.030 Why?
Withholding Treatment120166170.030 Why?
Longitudinal Studies22019146050.030 Why?
Antibiotic Prophylaxis120176360.020 Why?
Perception1201811970.020 Why?
Drug Administration Schedule1201948530.020 Why?
Medically Uninsured120178360.020 Why?
Mast Cells1201813920.020 Why?
Depression2202381240.020 Why?
Salvage Therapy1201712640.020 Why?
Education, Medical, Graduate1202323730.020 Why?
Adaptation, Psychological1202126290.020 Why?
Educational Status1201725220.020 Why?
Pilot Projects1202386310.020 Why?
Hematopoietic Stem Cells1202133960.020 Why?
DNA, Bacterial1201314790.020 Why?
Income1201718770.020 Why?
Genome, Bacterial120137830.020 Why?
Social Class1201720040.020 Why?
Immunocompromised Host120138560.020 Why?
Patient Acceptance of Health Care1202132050.020 Why?
Angiogenesis Inhibitors1201720470.020 Why?
Mice, Transgenic1201995390.020 Why?
Diarrhea1201313180.020 Why?
Genomics1202258210.020 Why?
Patient Selection1201842440.020 Why?
Dose-Response Relationship, Drug12018107660.020 Why?
Immunotherapy1202246520.020 Why?
Phylogeny1201328110.020 Why?
Poverty1201726980.020 Why?
Physician-Patient Relations1201832490.020 Why?
Population Surveillance1201525980.020 Why?
Evidence-Based Medicine1201636880.010 Why?
Logistic Models12019132550.010 Why?
Polymerase Chain Reaction1201360750.010 Why?
Cell Line, Tumor12020169810.010 Why?
Odds Ratio1201696460.010 Why?
Multivariate Analysis12017120590.010 Why?
Medicaid1201728180.010 Why?
Cell Differentiation12021115280.010 Why?
DNA Methylation1201743980.010 Why?
Immunohistochemistry12016110760.010 Why?
Mice22020815250.010 Why?
Proportional Hazards Models12017124630.010 Why?
Sequence Analysis, DNA1201347400.010 Why?
Databases, Factual1201779670.010 Why?
Colonic Neoplasms1201325380.010 Why?
Disease Models, Animal12020182520.010 Why?
Adolescent22021883190.010 Why?
Child22021801530.010 Why?
Pandemics1202086540.010 Why?
Prevalence12016157320.010 Why?
Time Factors12016399670.010 Why?
Hobbs's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (290)
Explore
_
Co-Authors (145)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.